Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07753980) titled 'Presentations and Outcomes of Acute Pancreatitis' on Aug. 04. Brief Summary: Evaluate the ... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754773) titled 'Motus Nova Foot Device for Patients With Hemiplegia' on March 05. Brief Summary: Individua... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754981) titled 'Self-Help Booklets for Sleep in Adults With Pulmonary Hypertension' on July 27. Brief Summ... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More